4C Pharma Solutions Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • 4C Pharma Solutions's estimated annual revenue is currently $24.5M per year.(i)
  • 4C Pharma Solutions's estimated revenue per employee is $201,000

Employee Data

  • 4C Pharma Solutions has 122 Employees.(i)
  • 4C Pharma Solutions grew their employee count by 17% last year.

4C Pharma Solutions's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Information TechnologyReveal Email/Phone
3
Safety associateReveal Email/Phone
4
Drug Safety Associate - Vigilance ReportingReveal Email/Phone
5
Senior drug safety associateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is 4C Pharma Solutions?

4C Pharma Solutions is a SPO (Service Processing Organization), owned and managed by Medical Doctors with years of domain expertise ranging from grass-root levels to managing operations at various Pharmaceutical manufacturers (ranging from small to large) and Pharmacovigilance Service Providers; We are expertised in providing services including medical information call center to receive and follow up case report information, registering, and triaging Adverse Event reports. We are also well equipped to accomplish End to End Case Processing including Full Data Entry, Medical Coding, Narrative Writing, Quality Check, Medical Review, Seriousness, Labeling and Causality assessments, and Electronic Submission of Individual Case Safety Reports (ICSRs) to Regulatory Authorities and MAH partners

keywords:N/A

N/A

Total Funding

122

Number of Employees

$24.5M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.8M123-3%N/A
#2
$12.4M12423%N/A
#3
$26.5M1264%$29M
#4
$35.9M1336%N/A
#5
$35M1334%N/A